Global X MLP ETF has delivered over 380% total returns in the past 5 years, but prior to 2020, returns were negative. MLPA offers a 6.82% trailing 12-month yield, solid liquidity, and competitive cost, making it an interesting compromise within its category. It doesn't seem to have major issues with NAV, with 100% of distributions coming in the form of ROC.

I recommend the Capital Group Dividend Value ETF for its resilience during market volatility and potential for long-term outperformance through high-quality dividend stocks. CGDV's strategy includes a focused portfolio of 52 holdings, with significant exposure to industrial, healthcare, and technology sectors, enhancing its total return potential. Despite a low starting dividend yield of 1.5%, the Fund's holdings have strong free cash flows, indicating substantial future dividend growth.

BOSTON , March 23, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has agreed to sell an aggregate of 10,250,000 shares of its common stock and warrants to purchase up to 10,250,000 shares of common stock priced at-the-market under Nasdaq rules, at a purchase price of $0.98 per share and associated warrant. The warrants will have an exercise price of $0.86 per share and will be immediately exercisable upon issuance for a period of five years following the date of issuance.

Intends to use Proceedings to Conduct a Value-Maximizing Sale Process and Resolve Liabilities Company Expects to Continue Business Operations in the Ordinary Course During Proceedings; Secures Commitment for Approximately $35 Million in DIP Financing to Support Ongoing Operations No Changes to Customer Data Management and Access; Company Remains Committed to Transparency Around Customer Data Privacy; Any Buyer will be Required to Comply with Applicable Law with Respect to Treatment of Customer Data Company Announces Board and Leadership Changes to Support Restructuring and Sale Process SAN FRANCISCO, March 23, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: …

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your Elastic N.V. (NYSE:ESTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elastic-n-v-lawsuit-submission-form?prid=138161&wire=1 or contact Joseph E.

Kingstone Companies saw a 31% growth in core business premiums in 2024 due to market dislocation from competitors exiting New York. The company reported a significant improvement in EBITDA, achieving $30 million in 2025 versus a loss in 2023, with a net income of $18.3 million. Kingstone's strong balance sheet, with $17 million net cash and strategic focus on core business areas position it for continued growth.

NEW YORK, March 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tungray Technologies Inc (NASDAQ: TRSG) resulting from allegations that Tungray Technologies may have issued materially misleading business information to the investing public.

NEW YORK, March 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Elastic N.V. (NYSE: ESTC) between May 31, 2024 and August 29, 2024, both dates inclusive (the “Class Period”), of the important April 14, 2025 lead plaintiff deadline.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=138160&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your enCore Energy Corp. (NASDAQ:EU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/encore-energy-corp-lawsuit-submission-form?prid=138158&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your e.l.f. Beauty, Inc. (NYSE:ELF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/e-l-f-beauty-lawsuit-submission-form?prid=138159&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your AppLovin Corporation (NASDAQ:APP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applovin-corporation-lawsuit-submission-form?prid=138157&wire=1 or contact Joseph E. Levi, Esq.

RADNOR, Pa., March 23, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Maravai LifeSciences Holdings, Inc. (“Maravai”) (NASDAQ: MRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7, 2024, and February 24, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 5, 2025.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your Alarum Technologies Ltd. (NASDAQ:ALAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/alarum-technologies-ltd-lawsuit-submission-form?prid=138155&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of NAPCO Security Technologies, Inc. (NASDAQ: NSSC) resulting from allegations that NAPCO may have issued materially misleading business information to the investing public. SO WHAT: If you purchased NAPCO securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your enCore Energy Corp. (NASDAQ:EU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/encore-energy-corp-lawsuit-submission-form?prid=138156&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Electronic Arts Inc. (NASDAQ:EA) resulting from allegations that EA may have issued materially misleading business information to the investing public. SO WHAT: If you purchased EA securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of enCore Energy Corp. (NASDAQ:EU) between March 28, 2024 and March 2, 2025, both dates inclusive (the "Class Period"), of the important May 13, 2025 lead plaintiff deadline. SO WHAT: If you purchased enCore securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your Atkore Inc. (NYSE:ATKR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atkore-inc-lawsuit-submission-form?prid=138154&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, March 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of e.l.f. Beauty, Inc. (“Elf”) (NYSE: ELF) between November 1, 2023 and November 19, 2024, both dates inclusive (the “Class Period”), of the important May 5, 2025 lead plaintiff deadline.